The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?
Those opposing vaccinations often mistrust government, science and the news media. There may be better ways to persuade them than by offering facts only.
Those opposing vaccinations often mistrust government, science and the news media. There may be better ways to persuade them than by offering facts only.
As Russia fast tracks a coronavirus vaccine, scientists worry about skipped safety checks – and the potential fallout for trust in vaccines if something ends up going wrong.
The results from the phase 1 trial are a promising first step in showing that the mRNA vaccine is a viable candidate, but there are unanswered questions and it is still early in the process.
The results from the phase 1 trial are a promising first step in showing that the mRNA vaccine is a viable candidate, but there are unanswered questions and it is still early in the process.
The high cost of pharmaceuticals often means only the richest patients get lifesaving medicines. As coronavirus drugs emerge, it will require hard, creative work to ensure they're available to all.
Nanoparticles dressed up in cell membranes snag SARS-CoV-2 virus particles before they reach human cells.
The UK is investing heavily in preparation for mass manufacturing of a working COVID-19 vaccine.
The UK is investing heavily in preparation for mass manufacturing of a working COVID-19 vaccine.
/
4
